Valuation (52%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 13.98 |
| PEG Ratio (TTM) | N/A | -2.50 |
| P/S Ratio (TTM) | 0.76 | 2.55 |
| P/B Ratio (TTM) | 1.14 | 1.81 |
| P/FCF Ratio (TTM) | 33.61 | 26.33 |
| Price to 5YR AVG Earnings Ratio | 34.61 | 16.92 |
| Price to 5YR AVG FCF Ratio | 8.88 | 32.63 |
Profitability (3%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 5.69% |
| ROE (TTM) | N/A | 13.93% |
| Net Profit Margin (TTM) | N/A | 19.17% |
| ROIC 5YR AVG | 0.96% | 3.16% |
Growth (83%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 28.15% | 443.60% | 250.45% |
| Revenue | -12.28% | 98.91% | 89.77% |
| Net Income | 33.91% | 510.09% | 292.21% |
| Cash Flow | -39.94% | 403.46% | 279.88% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.69 | 6.74 |
| Quick Ratio (TTM) | 4.69 | 7.07 |
| D/E Ratio (TTM) | 0.50 | 0.26 |
| Interest Coverage (TTM) | -2.09 | 9.66 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.11 | 2.57 |
| LTL to 5YR AVG FCF | 4.26 | 4.20 |
| Shares Outstanding Growth 5YR AVG | -1.13% | -2.28% |